Kepley Biosystems, a North Carolina biotechnology company, which uses extracts from the haemolymph of farm-raised horseshoe crabs, has been awarded a $1 million grant.
We use cookies to improve your experience, analyse site traffic and understand where our audience comes from. Accept all cookies, or continue with only those essential to running the site. See our Privacy & cookie policy.
